GlassScriptPhysician profile
Brooke H Lancaster
NPI 1609368463
$724.31
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $460 · 2022: $75.06 · 2023: $98.31 · 2024: $90.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.31 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $90.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.31 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $90.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $106.80 | 2021-2023 | Eliquis |
| Abbvie INC. | $90.50 | 2024 | |
| Abbott Laboratories | $65.75 | 2021-2023 | Amplatzer Amulet |
| Amarin Pharma, INC. | $62.96 | 2021 | |
| Alkermes, INC. | $62.25 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.90 | 2021-2023 | Lifevest |
| Amgen INC. | $55.17 | 2021-2023 | Repatha |
| Actelion Pharmaceuticals US, INC. | $51.18 | 2021 | |
| Pfizer INC. | $47.06 | 2021 | |
| Novartis Pharmaceuticals Corporation | $29.38 | 2021 | |
| Janssen Pharmaceuticals, INC | $27.08 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.75 | 2021 | |
| Amryt Pharma Holdings LTD | $15.24 | 2021 | |
| Boston Scientific Corporation | $14.34 | 2021 | |
| Merck Sharp & Dohme LLC | $13.67 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Lancaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.